Compensation For COVID-19 Vaccine Injuries In India: Stark Fault Lines?
Executive Summary
Scrip discusses with a cross-section of experts the complexities around pursuing compensation for COVID-19 vaccine-related injuries in India. Is there a case for ‘absolute liability’ for all injuries related to the two fast-tracked vaccines currently available, or alternatively a no-fault compensation program?
You may also be interested in...
The Indemnity Calculus For Covid-19 Vaccines, India’s Path Ahead
Legal experts discuss the intricacies around pharma’s demand for indemnity, a key sticking point for supplies of COVID-19 vaccines from Pfizer and Moderna, and the path forward for countries like India.
The Indemnity Calculus For Covid-19 Vaccines, India’s Path Ahead
Legal experts discuss the intricacies around pharma’s demand for indemnity, a key sticking point for supplies of COVID-19 vaccines from Pfizer and Moderna, and the path forward for countries like India.
The Indemnity Calculus For Covid-19 Vaccines, India’s Path Ahead
Legal experts discuss the intricacies around pharma’s demand for indemnity, a key sticking point for supplies of COVID-19 vaccines from Pfizer and Moderna, and the path forward for countries like India.